GE Healthcare and Adventist sign performance enhancement collaboration
Category: #health  By Mateen Dalal  Date: 2019-03-07
  • share
  • Twitter
  • Facebook
  • LinkedIn

GE Healthcare and Adventist sign performance enhancement collaboration

The five-year collaboration is expected to bring about financial improvement amounting to almost $100 million.

GE Healthcare and Adventist Health, two of the most renowned healthcare providers in the U.S. recently announced that in a collaboration they will be helping in the transformation of patient experience and healthcare delivery across a hospital system that includes 21 hospitals in Oregon, California and Hawaii.

The companies said that together, over the next 5 years, they would maximize the hospital system’s clinical asset capacity and utilize them to improve patient care delivery. The partnership also aims at providing better information to health system leaders via advanced analytics and improve the quality and reliability of care by reducing process variation. The collaboration is also anticipated to yield cost-saving efficiencies and enable growth that will lead to financial improvement amounting to almost $100 million over five years.

Bill Wing, President, Adventist Health has been reported to say that together with GE Healthcare, the collaboration is expected to deliver patient-centric, innovative care aiming to improving the health experience of the community while making it more affordable and accessible.

John Beaman, chief business officer at Adventist Health has been reported to say that Adventist is looking forward to continuing its relationship with GE Healthcare as the company brings expertise, access to market-leading resources, proprietary tools and advanced analytics into the collaboration. Beaman said that this offers Adventist the opportunity to improve its service, intensify utilization of assets to provide higher quality care and provide more alignment across its service program.

For the record, the strategic risk-sharing relationship between Adventist Health and GE Healthcare is fifth of the various long-term collaborations that GE has entered into over the last two years. Other performance enhancing partnerships include collaboration with Hartford Healthcare, Jefferson Health, Lifespan, Temple Health, Mission Health and Navicent Health.

Helen Stewart, managing principal, GE Healthcare Partners has commented on the latest collaboration and said that the long-term advantages of the partnership has been apparent to Adventist Health which is seeking to advance its goal and growth strategies and redesign the future of healthcare for its communities.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
Ambrx partners with Bristol-Meyers to initiate Relaxin clinical trial
By Mateen Dalal

Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical company focused on developing protein therapeutics, has recently announced that Bristo...

LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
LifeSpan Bio acquires Everest Biotech to expand reagent portfolio
By Mateen Dalal

The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of life science research reagents and antibodies, has recently announced that it has acqu...

AbbVie buys Mavupharma to target STING pathway for cancer treatment
AbbVie buys Mavupharma to target STING pathway for cancer treatment
By Mateen Dalal

AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon Genes pathway for the treatment o...